-
Je něco špatně v tomto záznamu ?
Increased liver oxidative stress and altered PUFA metabolism precede development of non-alcoholic steatohepatitis in SREBP-1a transgenic spontaneously hypertensive rats with genetic predisposition to hepatic steatosis
H. Malínská, O. Oliyarnyk, M. Hubová, V. Zídek, V. Landa, M. Šimáková, P. Mlejnek, L. Kazdová, TW. Kurtz, M. Pravenec
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem
Grantová podpora
NR9387
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Část
Zdroj
NLK
ProQuest Central
od 1997-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1997-01-01 do Před 1 rokem
- MeSH
- genetická predispozice k nemoci MeSH
- játra metabolismus patologie MeSH
- krysa rodu rattus MeSH
- lidé MeSH
- nenasycené mastné kyseliny metabolismus MeSH
- oxidační stres MeSH
- potkani inbrední SHR MeSH
- potkani transgenní MeSH
- protein SREBP1 genetika metabolismus MeSH
- ztučnělá játra genetika metabolismus patologie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
The temporal relationship of hepatic steatosis and changes in liver oxidative stress and fatty acid (FA) composition to the development of non-alcoholic steatohepatitis (NASH) remain to be clearly defined. Recently, we developed an experimental model of hepatic steatosis and NASH, the transgenic spontaneously hypertensive rat (SHR) that overexpresses a dominant positive form of the human SREBP-1a isoform in the liver. These rats are genetically predisposed to hepatic steatosis at a young age that ultimately progresses to NASH in older animals. Young transgenic SHR versus SHR controls exhibited simple hepatic steatosis which was associated with significantly increased hepatic levels of oxidative stress markers, conjugated dienes, and TBARS, with decreased levels of antioxidative enzymes and glutathione and lower concentrations of plasma alpha- and gamma-tocopherol. Transgenic rats exhibited increased plasma levels of saturated FA, decreased levels of n-3 and n-6 polyunsaturated FA (PUFA), and increased n-6/n-3 PUFA ratios. These results are consistent with the hypothesis that excess fat accumulation in the liver in association with increased oxidative stress and disturbances in the metabolism of saturated and unsaturated fatty acids may precede and contribute to the primary pathogenesis of NASH.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12025532
- 003
- CZ-PrNML
- 005
- 20140717085848.0
- 007
- ta
- 008
- 120816s2010 ne f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1007/s11010-009-0248-5 $2 doi
- 035 __
- $a (PubMed)19756959
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Malínská, Hana $7 xx0158953 $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 245 10
- $a Increased liver oxidative stress and altered PUFA metabolism precede development of non-alcoholic steatohepatitis in SREBP-1a transgenic spontaneously hypertensive rats with genetic predisposition to hepatic steatosis / $c H. Malínská, O. Oliyarnyk, M. Hubová, V. Zídek, V. Landa, M. Šimáková, P. Mlejnek, L. Kazdová, TW. Kurtz, M. Pravenec
- 520 9_
- $a The temporal relationship of hepatic steatosis and changes in liver oxidative stress and fatty acid (FA) composition to the development of non-alcoholic steatohepatitis (NASH) remain to be clearly defined. Recently, we developed an experimental model of hepatic steatosis and NASH, the transgenic spontaneously hypertensive rat (SHR) that overexpresses a dominant positive form of the human SREBP-1a isoform in the liver. These rats are genetically predisposed to hepatic steatosis at a young age that ultimately progresses to NASH in older animals. Young transgenic SHR versus SHR controls exhibited simple hepatic steatosis which was associated with significantly increased hepatic levels of oxidative stress markers, conjugated dienes, and TBARS, with decreased levels of antioxidative enzymes and glutathione and lower concentrations of plasma alpha- and gamma-tocopherol. Transgenic rats exhibited increased plasma levels of saturated FA, decreased levels of n-3 and n-6 polyunsaturated FA (PUFA), and increased n-6/n-3 PUFA ratios. These results are consistent with the hypothesis that excess fat accumulation in the liver in association with increased oxidative stress and disturbances in the metabolism of saturated and unsaturated fatty acids may precede and contribute to the primary pathogenesis of NASH.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a nenasycené mastné kyseliny $x metabolismus $7 D005231
- 650 _2
- $a ztučnělá játra $x genetika $x metabolismus $x patologie $7 D005234
- 650 _2
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a játra $x metabolismus $x patologie $7 D008099
- 650 _2
- $a oxidační stres $7 D018384
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani inbrední SHR $7 D011918
- 650 _2
- $a potkani transgenní $7 D055647
- 650 _2
- $a protein SREBP1 $x genetika $x metabolismus $7 D051780
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Oliyarnyk, Olena $7 xx0095365
- 700 1#
- $a Hubová, Miriam. $7 _AN041169
- 700 1_
- $a Zídek, Václav, $d 1951- $7 xx0088482
- 700 1_
- $a Landa, Vladimír $7 xx0062600
- 700 1_
- $a Šimáková, Miroslava $7 xx0094363
- 700 1_
- $a Mlejnek, Petr $7 xx0148186
- 700 1_
- $a Kazdová, Ludmila, $d 1938- $7 xx0053119
- 700 1_
- $a Kurtz, Theodore W
- 700 1_
- $a Pravenec, Michal, $d 1953- $7 nlk20030127611
- 773 0_
- $w MED00003385 $t Molecular and cellular biochemistry $x 1573-4919 $g Roč. 335, č. 1-2 (2010), s. 119-125
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/19756959 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120816 $b ABA008
- 991 __
- $a 20140717090151 $b ABA008
- 999 __
- $a ok $b bmc $g 947574 $s 782878
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2010 $b 335 $c 1-2 $d 119-125 $i 1573-4919 $m Molecular and cellular biochemistry $n Mol Cell Biochem $x MED00003385
- GRA __
- $a NR9387 $p MZ0
- LZP __
- $a Pubmed-20120816/10/02